ARCHIVES

Doxil/Caelyx Survival 3 Weeks Longer Than Topotecan

This article is from The Cancer Letter archive.

Vol. 26 No. 11 | November 28, 2003

Download PDF Visit The Full Archive

Related Articles

Senate Debates $1.1 Trillion “Cromnibus” Bill That Includes a $150 Million Increase for NIH

December 12, 2014

Cancer Accounts for 23% of U.S. Deaths, American Cancer Society Says.

January 21, 2005

ASCO Annual Report Names Significant Clinical Research Advances Of Past Year

December 25, 2009

NCI Begins PLCO Screening Trial

November 26, 1993

Early, Short Course Of Hormonal Therapy May Allow Patients To Live Longer

January 25, 2008

Five Investigations Probe NIH Radiation Contamination

November 17, 1995